Insider transaction: Ryman Healthcare CEO & CFO disclose on market share purchases (NZ$2.60, 0.00)
Street Takeaways - Ryman Healthcare Q1 trading update (NZ$2.55, +0.05)
StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday
Ryman Healthcare provides update in presentation (NZ$2.19, 0.00)
Ryman Healthcare reports CFO Rob Woodgate resigns (NZ$2.24, 0.00)
StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (69 total)
Ryman Healthcare reports FY NPAT (NZ$436.8M) vs year-ago (NZ$169.7M) (NZ$2.41, 0.00)
Powered by FactSet Research Systems Inc.